Claims
- 1. The method of preventing or relieving thrombosis in a warm-blooded animal in need thereof, which comprises perorally, parenterally or rectally administering to said animal an effective antithrombotic amount of a compound of the formula ##STR13## wherein R.sub.1 is methoxy; ethoxy; 2-hydroxy-ethoxy; (alkyl of 1 to 8 carbon atoms)mercapto; cyclohexylmercapto; phenethylmercapto; 1-phenylethyl-mercapto; 3-phenylpropyl-mercapto; 2-diethylaminoethyl-mercapto; 1-naphthylmethyl-mercapto, furfuryl-mercapto; 2-indanyl-mercapto; (unsubstituted or mono-substituted phenyl)mercapto, where the substituent is fluorine, chlorine, bromine, methyl, hydroxyl, methoxy or amino; (unsubstituted or mono-substituted benzyl)mercapto, where the substituent is attached to the phenyl moiety and is fluorine, chlorine, methyl, hydroxyl, methoxy, nitro or trifluoromethyl; dichlorobenzyl-mercapto; methylenedioxybenzyl-mercapto; dimethoxybenzyl-mercapto; thiomorpholino; thiomorpholino-1-oxide; (unsubstituted or mono-hydroxy-substituted alkyl of 1 to 4 carbon atoms)-amino; N,N-di(unsubstituted or mono-hydroxy-substituted alkyl of 1 to 4 carbon atoms)-amino; phenyl(alkyl of 1 to 4 carbon atoms)-amino; N-(alkyl of 1 to 4 carbon atoms)-phenyl-(alkyl of 1 to 4 carbon atoms)-amino; phenyl-amino; or N-(alkyl of 1 to 4 carbon atoms)-phenylamino; and
- R.sub.3 is hydrogen; formyl; 2-furoyl; or 2-thenoyl; or a non-toxic, pharmacologically acceptable acid addition salt thereof.
- 2. The method of claim 1,
- where
- R.sub.1 is 2-hydroxy-ethoxy; (unsubstituted or mono-substituted benzyl)mercapto, where the substituent is methyl, methoxy, fluorine or chlorine; dichlorobenzylthio; dimethoxybenzylthio; benzylamino; N-methyl-benzylamino; or 2-phenylethyl-amino; and
- R.sub.3 is hydrogen, formyl or furoyl.
- 3. The method of claim 1,
- where
- R.sub.1 has the meanings defined in claim 1; and
- R.sub.3 is hydrogen.
- 4. The method of claim 1,
- where
- R.sub.1 is benzylamino, N-methyl-benzylamino, benzylthio, dichlorobenzylthio or dimethoxybenzylthio; and
- R.sub.3 is hydrogen.
- 5. The method of claim 1, where said compound is 8-benzylthio-4-morpholino-2-piperazino-pyrimido[5,4-d]pyrimidine or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Priority Claims (2)
Number |
Date |
Country |
Kind |
2926804 |
Jul 1979 |
DEX |
|
3013930 |
Apr 1980 |
DEX |
|
Parent Case Info
This is a continuation-in-part of co-pending application Ser. No. 350,429, filed Feb. 22, 1982, now abandoned; which in turn is a continuation of application Ser. No. 161,010, filed June 19, 1980, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3031450 |
Fischer et al. |
Apr 1962 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
209344 |
May 1960 |
ATX |
Non-Patent Literature Citations (1)
Entry |
Goodman et al., The Pharmacological Basis of Therapeutics, Fifth Edition, pp. XIII, XV, 653, 1308. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
161010 |
Jun 1980 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
350429 |
Feb 1982 |
|